Chronic lymphocytic leukaemia; stem cell graft versus host disease prophylaxis May with 2006 for No PBAC outside outside chronic Aus and application registered Nov registered Alemtuzumab 11 Yes or 19 None no funding NZ for cancer indications, 2009 indications, reduced indications no funding no funding intensity conditioning regimens; induction therapy for solid organ transplant including kidney, pancreas, liver and heart
Alemtuzumab Aus and NZ 11 Yes Chronic lymphocytic leukaemia; stem cell graft versus host disease prophylaxis with or reduced intensity conditioning regimens; induction therapy for solid organ transplant including kidney, pancreas, liver and heart 19 None May 2006 for chronic No PBAC application for cancer indications outside registered indications, no funding Nov 2009 no funding outside registered indications, no funding